International Journal of Drug Policy
Volume 16, Issue 4 , Pages 281-284 , August 2005

Safer injecting education for HIV prevention within a medically supervised safer injecting facility

  • Evan Wood

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • Department of Infectious Diseases, Faculty of Medicine, University of British Columbia, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 806 9116; fax: +1 604 806 9044.
    • ,
  • Mark W. Tyndall

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • Department of Infectious Diseases, Faculty of Medicine, University of British Columbia, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Jo-Anne Stoltz

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Will Small

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Ruth Zhang

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Jacqueline O’Connell

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Julio S.G. Montaner

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • Department of Infectious Diseases, Faculty of Medicine, University of British Columbia, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
    • ,
  • Thomas Kerr

      Affiliations

    • BC Centre for Excellence in HIV/AIDS, St. Paul's Hospital, 667-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6

Received 10 February 2005 ,Revised 6 July 2005 ,Accepted 27 July 2005.

References 

  1. Broadhead RS, Kerr TH, Grund J, Altice FL. Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues. 2002;32(1):329–355
  2. Des Jarlais DC, Friedman SR. Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports. 1998;113(Suppl. 1):182–188
  3. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–991
  4. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet. 1999;353(9165):1657–1661
  5. Dolan K, Kimber J, Fry C, Fitzgerald J, MacDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review. 2000;19:337–346
  6. Hagan H, McGough J, Thiede H, Weiss NS, Hopkins S. Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology. 1999;149:203–213
  7. Kerr T, Wodak A, Elliot L, Montaner J, Wood E. Opiod substitution therapy and HIV/AIDS treatment and prevention. Lancet. 2004;364(9449):1918–1919
  8. Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Canadian Medical Association Journal. 2003;169(8):759–763
  9. Kral A, Bluthenthal R, Erringer E, Lorvick J, Edlin B. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–683
  10. Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, Edlin B. Sexual transmission of HIV-1 among injection drug users in San Francisco USA: Risk-factor analysis. Lancet. 2001;357(9266):1397–1401
  11. O’Connell, J. M., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J. S., et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, in press.
  12. Strathdee S, Galai N, Safaiean M, Celentano D, Vlahov D, Johnson L, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Archives of Internal Medicine. 2001;161:1281–1288
  13. Tyndall M, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy M, et al. Intensive injection cocaine use as the primrary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–893
  14. Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: Preventing transition into injection. Journal of Urban Health. 2004;81(1):14–19
  15. Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal. 2004;1(1):9
  16. Wood E, Kerr T, Montaner J, Strathdee S, Wodak A, Hankins C, et al. Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infectious Diseases. 2004;4:301–306
  17. Wood E, Spittal P, Kerr T, Small W, Tyndall M, O'Shaughnessy M, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Canadian Journal of Public Health. 2003;94(5):355–359
  18. Wood E, Tyndall M, Spittal P, Li K, Hogg R, Montaner J, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16(6):941–943
  19. Wood E, Tyndall M, Spittal P, Li K, Hogg R, O'Shaughnessy M, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. International Journal of Drug Policy. 2002;13(2):95–102
  20. Wright NM, Tompkins CN. Supervised Injecting centres. British Medical Journal. 2004;328:100–102

PII: S0955-3959(05)00102-7

doi: 10.1016/j.drugpo.2005.07.004

International Journal of Drug Policy
Volume 16, Issue 4 , Pages 281-284 , August 2005

Article Tools